echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Acta Derm Venereol: transplantation of non-cultured autologous epidermal cells suspended in hyaluronic acid can effectively and safely treat vitiligo and alopecia areata

    Acta Derm Venereol: transplantation of non-cultured autologous epidermal cells suspended in hyaluronic acid can effectively and safely treat vitiligo and alopecia areata

    • Last Update: 2021-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Vitiligo is a depigmentation or reduction of skin, mainly due to the massive loss of melanocytes
    .


    Due to its impact on appearance, vitiligo will seriously affect the quality of life of patients and increase the psychological burden of patients


    At present, the main treatment for vitiligo is a combination of phototherapy and topical anti-inflammatory drugs
    .


    For those patients who do not respond to treatment, autologous cell transplantation is considered a good option


    Recently, a randomized study published in Acta Derm Venereol evaluated non-cultured autologous epidermal cell transplantation resuspended in hyaluronic acid vs.
    Hyaluronic acid alone (neutral comparison agent), 6 months later for vitiligo and alopecia areata The effect of re-pigmentation of lesions
    .

    Each patient included in the study has two definite paired lesions, which are randomly assigned to any one device for treatment
    .


    The equipment with ready-to-use kits is prepared by different health professionals to maintain blindness


     

    As a result, of the 38 patients screened, 36 (94.
    7%) patients entered the final study analysis, which is equivalent to 72 lesions
    .


    For difficult-to-treat lesions, defined as lesions located in the wrists, elbows, and hands (n = 30), no repigmentation of ≥50% was observed


    In summary, the results of the study indicate that the single application of non-cultured epidermal cell transplantation using the ready-to-use kit is effective during the 6-month and 1-year follow-up
    .


    It is worth noting that this equipment does not require special facilities (cell culture) or hospitalization (surgery can be performed in an outpatient clinic)


     

    Original source:

     

    Antoine Bertolotti, et al.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.